胰岛移植与标准治疗对1型糖尿病合并严重低血糖的比较:来自协作胰岛移植登记处与T1D交换登记处的研究
本研究基于协作胰岛移植登记处(CITR)与T1D交换登记处(T1DX)的前瞻性数据,采用病例对照分析,比较胰岛移植与标准治疗对1型糖尿病合并严重低血糖事件(SHE)患者的长期血糖控制和肾功能影响。结果显示,胰岛移植组达到HbA1c<7.0%且无SHE的比例为71-80%,高于对照组的21-33%(P<0.001);但胰岛移植组估算肾小球滤过率下降幅度更大(-8.8至-20 vs. -1.3至-6.5 mL·min⁻¹·1.73m⁻²,P<0.001)。
要点
- 胰岛移植组达到HbA1c<7.0%且无SHE的比例为71-80%,显著高于标准治疗组的21-33%(P<0.001)。
- 胰岛移植组达到HbA1c≤6.5%且无SHE的比例为60-75%,显著高于标准治疗组的10-20%(P<0.001)。
- 胰岛移植组估算肾小球滤过率下降幅度大于标准治疗组(-8.8至-20 vs. -1.3至-6.5 mL·min⁻¹·1.73m⁻²,P<0.001)。
主要发现
- CITR组(n=71)对比T1DX组(n=213),5年内达到HbA1c<7.0%且无SHE的比例为71-80% vs. 21-33%(P<0.001)。
- CITR组对比T1DX组,5年内达到HbA1c≤6.5%且无SHE的比例为60-75% vs. 10-20%(P<0.001)。
- CITR组多数患者实现胰岛素非依赖,胰岛素需求量显著低于T1DX组。
- 估算肾小球滤过率从基线至5年的下降幅度,CITR组为-8.8至-20 mL·min⁻¹·1.73m⁻²,T1DX组为-1.3至-6.5 mL·min⁻¹·1.73m⁻²(P<0.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Islet transplantation was recently approved by the U.S. Food and Drug Administration for adults with type 1 diabetes complicated by recurrent severe hypoglycemia events (SHEs). We sought to understand the long-term benefit for glycemic control and risk of immunosuppression to kidney function associated with islet transplantation compared with ongoing standard of care. RESEARCH DESIGN AND METHODS: We performed a case-control analysis of prospectively collected data from patients in the Collaborative Islet Transplant Registry (CITR) with at least one SHE in the year (2000-2014) before transplantation (case subjects) and compared them with data from patients in the T1D Exchange (T1DX) Registry with at least one SHE in the year (2010-2012) before enrollment (control subjects), with both cohorts observed over 5 years. SHEs were restricted to those resulting in seizure or loss of consciousness. RESULTS: Case subjects from CITR (n = 71) compared with control subjects from T1DX (n = 213) more often achieved the primary outcome of HbA1c <7.0% and absence of an SHE (71-80% vs. 21-33% over 5 years; P < 0.001) and the outcome of HbA1c ≤6.5% and absence of an SHE (60-75% vs. 10-20%; P < 0.001) while requiring significantly less insulin (majority in CITR were insulin independent). Kidney function, measured by estimated glomerular filtration rate, declined from baseline to a greater extent in CITR than in T1DX (-8.8 to -20 vs. -1.3 to -6.5 mL ⋅ min-1 ⋅ 1.73 m-2 over 5 years; P < 0.001). CONCLUSIONS: Islet transplantation for adults with type 1 diabetes complicated by SHEs results in near-normal glycemic control in the absence of SHEs more often than observed with standard of care, but at the cost of greater reduction in kidney function.
引用
- Rickels MR, Ballou CM, Foster NC, et al. Islet Transplantation Versus Standard of Care for Type 1 Diabetes Complicated by Severe Hypoglycemia From the Collaborative Islet Transplant Registry and the T1D Exchange Registry. Diabetes Care. 2025. PMID: 39951130. doi:10.2337/dc24-1915
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。